The DNA forensics market will continue to be led by the sectors with applications in legal, law enforcement and biodefense environments.
The balance should shift, as therapeutics derived from forensics origins or incorporated into pharmacogenomic medicines assert a more dominant value in a $1.477 billion market by 2014.